U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07129486) titled 'Intermittent-Hypoxia Inhibits Neutrophil Extracellular Traps Formation: Role of Cathelicidins' on Aug. 12.
Brief Summary: The study will enroll 80 moderate-to-severe Obstructive sleep apnea (OSA) patients (40 obese) and 40 age-, gender-, and body mass index-matched controls. Venous blood will be collected to isolate neutrophils, which will be tested for the ability to produce neutrophil extracellular traps (NETs) along with the levels of LL-37 and NETs products in the blood. Measurements will be repeat after three months treatment for OSA.
Study Start Date: Aug., 2025
Study Type: OBSERVATIONAL
Condition:
Obstructive Sleep Apnea ...